T1	Participants 66 86	patients with cancer
T2	Participants 1155 1222	342 participants from the ongoing ESRA-C randomized clinical trial.
T3	Participants 1223 1597	Research participants for the ESRA-C study were recruited from the Seattle Cancer Care Alliance, a consortium among the University of Washington Medical Center, Fred Hutchinson Cancer Research Center, and Children's Hospital and Regional Medical Center in Seattle, WA. The sample consisted of 342 adult participants who completed both baseline and follow-up survey sessions.
T4	Participants 1598 1737	Medical oncology represented the largest recruitment group (45.3%), followed by stem cell transplant (34.5%) and radiation oncology (20.2%)
